In the model group, the expression levels of the epithelial biomarkers E-cadherin and ZO-1 were decreased, the expression of β-catenin was increased, and the expression of the mesenchymal biomarker N-cadherin was increased in the RCC xenografts. Here, CDH2 is linked to renal cell carcinoma.